Literature DB >> 2041244

Thermotolerance in regional hyperthermia in vivo--an experimental study using the MH134 tumor.

Y Matsuzaki1, M Yoshioka, T Yonezawa, T Onitsuka, K Shibata, Y Koga.   

Abstract

In the clinical application of hyperthermia, determining the thermotolerance that influences the anti-tumor effect is an important problem. The purpose of this study was to investigate the methods of induction and disappearance of thermotolerance in vivo. After transplanting MH134 cancer cells into the paws of C3H mice, local hyperthermia with warm water was administered, and the movement of thermotolerance in vivo studied in terms of the heating intervals and tumor growth times. When the first heating was applied on the 8th day after transplantation, thermotolerance appeared within 1 hour, increasing gradually to reach a maximum at 18 hours, after which it decreased gradually and disappeared after 48 hours. When the first heating was applied on the 13th day after transplantation, which fell during the rapid tumor proliferation period, the movement of thermotolerance presented a similar pattern of appearance and disappearance. The results of this study made it clear that there was no difference in the movement of thermotolerance between the two periods even though each had a different rate of tumor proliferation.

Entities:  

Mesh:

Year:  1991        PMID: 2041244     DOI: 10.1007/bf02470869

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  14 in total

1.  Induced thermal resistance in HeLa cells.

Authors:  E W Gerner; M J Schneider
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Influence of drugs and synchrony on the hyperthermic killing of HeLa cells.

Authors:  R J Palzer; C Heidelberger
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

3.  Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro.

Authors:  A Westra; W C Dewey
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1971

4.  Heat shock proteins within the mammalian cell cycle: relationship to thermal sensitivity, thermal tolerance, and cell cycle progression.

Authors:  G Rice; A Laszlo; G Li; J Gray; W Dewey
Journal:  J Cell Physiol       Date:  1986-02       Impact factor: 6.384

5.  Heat shock protein synthesis and cell survival in clones of normal and simian virus 40-transformed mouse embryo cells.

Authors:  R A Omar; K W Lanks
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

6.  Persistence of thermotolerance in slowly proliferating plateau-phase cells.

Authors:  L E Gerweck; T F DeLaney
Journal:  Radiat Res       Date:  1984-02       Impact factor: 2.841

7.  Induction of thermotolerance in Chinese hamster ovary cells by high (45 degrees) or low (40 degrees) hyperthermia.

Authors:  K J Henle; J E Karamuz; D B Leeper
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

8.  Heat sensitivity and thermotolerance in cells from five human melanoma xenografts.

Authors:  E K Rofstad; H Midthjell; T Brustad
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

9.  Relationship between hyperthermia-induced heat-shock proteins and thermotolerance in Morris hepatoma cells.

Authors:  J Landry; P Chrétien
Journal:  Can J Biochem Cell Biol       Date:  1983-06

10.  Influence of time and temperature on the kinetics of thermotolerance in L1A2 cells in vitro.

Authors:  O S Nielsen; J Overgaard
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

View more
  2 in total

1.  Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion.

Authors:  Youngkyu Moon; Kyung Soo Kim; Jae Kil Park
Journal:  J Cardiothorac Surg       Date:  2015-10-28       Impact factor: 1.637

2.  Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion.

Authors:  Yi-Jing Cheng; Ching-Kai Lin; Chao-Yu Chen; Po-Chien Chien; Ho-Hsien Chuan; Chao-Chi Ho; Yun-Chien Cheng
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.